Skip to search formSkip to main contentSkip to account menu

eleutherin

Known as: (1R,3S)-9-Methoxy-1,3-dimethyl-3,4-dihydro-1H-benzo(g)isochromene-5,10-dione 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background: the plant of Eleutherine palmifolia Had been proven could inhibit the growth of Escherichia coli bacteria and… 
Review
2013
Review
2013
................................................................................................................................... vii CHAPTER 1 : INTRODUCTION ......................................................................................... 1 1.1 The pyranonaphthoquinone antibiotics ............................................................................... 3 1.2 The biological properties of pyranonaphthoquinone antibiotics ......................................... 5 1.3 Recent synthetic approaches to the pyranonaphthoquinone antibiotics .............................. 9 1.3.1 Electrophilic substitution .............................................................................................. 9 1.3.2 Electrophilic substitution and cyclization ................................................................... 11 1.3.2.1 Dotz benzannulation and oxa-Pictet-Spengler cyclization .................................. 11 1.3.2.2 Heck coupling and oxa-Pictet-Spengler cyclization ............................................ 24 1.3.3 Electrophilic cyclization ............................................................................................. 25 1.3.3.1 Asymmetric α-aminooxylation and oxa-Pictet-Spengler cyclization .................. 25 1.3.4 Electrophile-induced cyclization ................................................................................ 28 1.3.5 Organopalladium catalyzed cyclization ...................................................................... 34 1.3.6 Radical conjugate addition .......................................................................................... 40 1.3.7 Diels-Alder cycloaddition ........................................................................................... 43 1.3.8 Phthalide annulation ................................................................................................... 46 1.7.9 Toluate anion annulation ............................................................................................ 58 1.4 The dimeric pyranonapthoquinone antibiotic crisamicin A 18: isolation, biological properties and structure ..................................................................................................... 63 1.5 Aim of the present research ............................................................................................... 65 CHAPTER 2 : DISCUSSION ............................................................................................... 69 2.1 Overview ........................................................................................................................... 71 2.2 Synthesis of chiral (S,S)-enone 407 ................................................................................... 72 2.2.1 Attempted approach towards (S,S)-enone 407 ............................................................ 72 2.2.2 Revised synthetic route to (S,S)-enone 407 ................................................................ 77 
2009
2009
Two microscale separation techniques for the analysis of bioactive naphthoquinones in Eleutherine americana were developed and… 
2009
2009
OBJECTIVE To research the chemical constituents from Eleutherine americana. METHODS Column chromatography with silica gel was… 
2009
2009
Objective:To develop an HPLC for content determination of three biologically active components(isoeleutherin,eleutherin and… 
2006
2006
A new synthetic approach to enantiopure pyranonaphthoquinones is described. (S)-Mellein 10, prepared in 6 steps from (S… 
2000
2000
Pyranonaphthoquinones have diverse biological activities against Gram-positive bacteria, fungi, and mycoplasms, and, recently… 
1995
1995
A genera) synthetic strategy has been developed for the synthesis of racemic 3,4-dihydro-3-methyl-1 Hbenzo[ c]pyran-5,8-dione 25… 
1957
1957
The synthesis of (±)-Eleutherine and (±)-Isoeleutherine is described.